<DOC>
	<DOCNO>NCT00160446</DOCNO>
	<brief_summary>The objective study determine safety effectiveness three dos asoprisnil , compare placebo , treatment woman endometriosis .</brief_summary>
	<brief_title>A Study Evaluate Safety Effectiveness Three Asoprisnil Doses Treatment Women With Endometriosis</brief_title>
	<detailed_description>Endometriosis , presence endometrial tissue outside uterus , progressive , estrogen-dependent disease occur menstruate woman reproductive age . Although major endometriosis therapy effective treatment pain , single treatment superior others term efficacy . The major drawback current medical therapy severe side effect hot flush osteoporosis . The objective study determine safety efficacy asoprisnil 5 , 10 , 25 mg tablet , compare placebo , administer daily 12 week woman endometriosis , assess whether asoprisnil administration diminishes pelvic pain , dysmenorrhea , dyspareunia , excessive bleeding , analgesic use associate disease lessen subject ' perceive pain symptom . Otherwise healthy woman surgically confirm endometriosis enrol .</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<criteria>Surgically confirm endometriosis History menstrual cycle 26 32 day Otherwise good health Age 1840 year , inclusive Subject pain grade Screening Day 1 accord scale suggest Biberoglu Berhman5 least one follow category : 1. moderate severe pelvic pain related menstruation , OR 2. moderate severe dysmenorrhea , OR 3. moderate severe pelvic tenderness elicit pelvic examination accompany nonmenstrual pelvic pain . Subject agree double barrier method contraception Any abnormal lab procedure result studydoctor considers important History undiagnosed uterine bleed gynecological disorder Severe reaction ( ) hormone therapy History osteoporosis metabolic bone disease Subject currently breast feeding</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Pelvic pain</keyword>
	<keyword>Dysmenorrhea</keyword>
	<keyword>Dyspareunia</keyword>
	<keyword>Infertility</keyword>
	<keyword>Asoprisnil</keyword>
</DOC>